Delivery Order SPE2DB22D2218-SPE2DB24FR2BG
Award Date
2/20/24
Potential Completion Date
2/21/24
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product, with a completion date of February 21, 2024 and a potential value of $24,203.68. This delivery order is issued under an indefinite delivery contract (IDC) awarded by...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML. The contract has an ultimate completion date of July 17, 2024 and a ceiling value of $26,863.44. This contract is not set aside and is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product, with a potential value of $1,973.01 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver this medical product to support military treatment programs and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $42,619.78 contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product, with an ultimate completion date of September 10, 2024. This contract is not set aside for any specific business size or type. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs)...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $15,928.06 firm-fixed-price contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a prescription medication. The contract has an ultimate completion date of August 12, 2024 and was awarded on August 9, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMULIN R 500 UNIT/ML KWIKPEN 3ML. The contract has a ceiling value of $2,236.32 and a period of performance through March 18, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the provision of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product, with a potential value of $10,914.54 and a period of performance through February 2, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,236.32 firm fixed-price delivery order is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of September 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a brand-name pharmaceutical product, with a potential value of $34,834.73 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML. The contract has a ceiling value of $1,285.93 and an ultimate completion date of September 11, 2024. It is a firm fixed-price contract, with no set-aside designation. This award is a part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...